Contract Biomanufacturing

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Outsourcing is booming across all platforms, from fill/finish to cell therapies, as companies pursue efficiency, scale, and strategic flexibility.

Felicity Thomas

Circio Expanding R&D in Sweden for Acceleration of Next-Gen Therapeutics

Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Stockholm, Sweden. Scenic summer sunset view with colorful sky of the Old Town architecture in Sodermalm district. | Image Credit: © Nikolay N. Antonov - stock.adobe.com

Piramal Pharma Breaks Ground on Kentucky Facility, Part of $90 Million Expansion Plan

Increased capacity will help Circio progress development of circVec AAV gene therapy and in-vivo cell therapy, with the company setting a goal of selecting its first therapeutic candidate in 2026.

Old rusty shovel in the ground on the building | Image Credit: © photolink - stock.adobe.com

BIO 2025: Speeding Up Development of Next-Generation Biologics

The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.

Abu Dhabi Health Department's US Mission Yields Multiple Strategic Agreements

Matthew Stober and Campbell Bunce of Abzena talk about the CDMO’s role in accelerating the path of newer and more effective modalities to market.

UAE flag waving in the sky, national symbol of UAE | Image Credit: © Freelancer - stock.adobe.com

Outsourcing Hits Record Levels for All Bioprocess Platforms

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

Related Content

Yasmin Timol

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Outsourcing is booming across all platforms, from fill/finish to cell therapies, as companies pursue efficiency, scale, and strategic flexibility.

Felicity Thomas

Circio Expanding R&D in Sweden for Acceleration of Next-Gen Therapeutics

Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Piramal Pharma Breaks Ground on Kentucky Facility, Part of $90 Million Expansion Plan

Increased capacity will help Circio progress development of circVec AAV gene therapy and in-vivo cell therapy, with the company setting a goal of selecting its first therapeutic candidate in 2026.

BIO 2025: Speeding Up Development of Next-Generation Biologics

The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.

Abu Dhabi Health Department's US Mission Yields Multiple Strategic Agreements

Matthew Stober and Campbell Bunce of Abzena talk about the CDMO’s role in accelerating the path of newer and more effective modalities to market.